Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Luster

Showing results (81-90 of 181) with videos related to

Pageof 19
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 13, 2010
Radioimmunotherapy with anti-CD66 antibody: improving the biodistribution using a physiologically based pharmacokinetic modelPeter Kletting, Thomas Kull, Donald Bunjes, et al.
Biomedicines|September 23, 2022
Real-Life Performance of F-18-FDG PET/CT in Patients with Cervical Lymph Node Metastasis of Unknown Primary TumorFriederike Eilsberger, Friederike Elisabeth Noltenius, Damiano Librizzi, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 19, 2015
Optimized Peptide Amount and Activity for ⁹⁰Y-Labeled DOTATATE TherapyPeter Kletting, Thomas Kull, Christian Maaß, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 18, 2017
The "reset button" revisited: why high activity <sup>131</sup>I therapy of advanced differentiated thyroid cancer after dosimetry is advantageous for patientsFrederik A Verburg, Markus Luster, Luca Giovanella, et al.
Molecules (Basel, Switzerland)|March 3, 2021
Clinical Relevance of [<sup>18</sup>F]Florbetaben and [<sup>18</sup>F]FDG PET/CT Imaging on the Management of Patients with DementiaDamiano Librizzi, Nicole Cabanel, Maxim Zavorotnyy, et al.
BMC Cancer|August 8, 2024
Diagnostic efficacy of [<sup>99m</sup>Tc]Tc-PSMA SPECT/CT for prostate cancer: a meta-analysisQi Wang, Svea Ketteler, Shamim Bagheri, et al.
The Laryngoscope|January 10, 2013
Detection of paranasal ectopic adrenocorticotropic hormone-secreting pituitary adenoma by Ga-68-DOTANOC positron-emission tomography-computed tomographyJohannes A Veit, Bernhard Boehm, Markus Luster, et al.
Journal of Cancer Research and Clinical Oncology|January 4, 2020
Prostate specific membrane antigen (PSMA) in urothelial cell carcinoma (UCC) is associated with tumor grading and stagingHenner Schreiber, Jörg Hänze, Wilhelm Nimphius, et al.
Endocrine Regulations|October 23, 2004
Real time RT-PCR analysis of thyroglobulin mRNA in peripheral blood in patients with congenital athyreosis and with differentiated thyroid carcinoma after stimulation with recombinant human thyrotropinSarah Kaufmann, Cornelia Schmutzler, Lutz Schomburg, et al.
Journal of Clinical Medicine|September 28, 2024
Match Point: Nuclear Medicine Imaging for Recurrent Thyroid Cancer in TENIS Syndrome-Systematic Review and Meta-AnalysisFabrizia Gelardi, Alexandra Lazar, Gaia Ninatti, et al.
Pageof 19

Showing results (81-90 of 181) with videos related to

Sort By:
Pageof 19
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 13, 2010
Radioimmunotherapy with anti-CD66 antibody: improving the biodistribution using a physiologically based pharmacokinetic modelPeter Kletting, Thomas Kull, Donald Bunjes, et al.
Biomedicines|September 23, 2022
Real-Life Performance of F-18-FDG PET/CT in Patients with Cervical Lymph Node Metastasis of Unknown Primary TumorFriederike Eilsberger, Friederike Elisabeth Noltenius, Damiano Librizzi, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 19, 2015
Optimized Peptide Amount and Activity for ⁹⁰Y-Labeled DOTATATE TherapyPeter Kletting, Thomas Kull, Christian Maaß, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 18, 2017
The "reset button" revisited: why high activity <sup>131</sup>I therapy of advanced differentiated thyroid cancer after dosimetry is advantageous for patientsFrederik A Verburg, Markus Luster, Luca Giovanella, et al.
Molecules (Basel, Switzerland)|March 3, 2021
Clinical Relevance of [<sup>18</sup>F]Florbetaben and [<sup>18</sup>F]FDG PET/CT Imaging on the Management of Patients with DementiaDamiano Librizzi, Nicole Cabanel, Maxim Zavorotnyy, et al.
BMC Cancer|August 8, 2024
Diagnostic efficacy of [<sup>99m</sup>Tc]Tc-PSMA SPECT/CT for prostate cancer: a meta-analysisQi Wang, Svea Ketteler, Shamim Bagheri, et al.
The Laryngoscope|January 10, 2013
Detection of paranasal ectopic adrenocorticotropic hormone-secreting pituitary adenoma by Ga-68-DOTANOC positron-emission tomography-computed tomographyJohannes A Veit, Bernhard Boehm, Markus Luster, et al.
Journal of Cancer Research and Clinical Oncology|January 4, 2020
Prostate specific membrane antigen (PSMA) in urothelial cell carcinoma (UCC) is associated with tumor grading and stagingHenner Schreiber, Jörg Hänze, Wilhelm Nimphius, et al.
Endocrine Regulations|October 23, 2004
Real time RT-PCR analysis of thyroglobulin mRNA in peripheral blood in patients with congenital athyreosis and with differentiated thyroid carcinoma after stimulation with recombinant human thyrotropinSarah Kaufmann, Cornelia Schmutzler, Lutz Schomburg, et al.
Journal of Clinical Medicine|September 28, 2024
Match Point: Nuclear Medicine Imaging for Recurrent Thyroid Cancer in TENIS Syndrome-Systematic Review and Meta-AnalysisFabrizia Gelardi, Alexandra Lazar, Gaia Ninatti, et al.
Pageof 19